Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
December 8, 2009
Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trial
Simone Krebs, Talib N Omer, Bilal Omer
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 17, 2010
Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial
Simone Krebs, Bilal Omer, Talib Noor Omer, et al.
Cancer Immunology Research
|
January 18, 2019
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors
Robin Parihar, Charlotte Rivas, Mai Huynh, et al.
Cancer Immunology Research
|
September 1, 2025
Tunneling CARs: Increasing CAR T-cell tumor infiltration through the overexpression of MMP-7 and Osteopontin-b
Stacey Van Pelt, Mark White, Candise Tat, et al.
British Journal of Haematology
|
July 11, 2012
Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults
Bilal Omer, Nina S Kadan-Lottick, Kenneth B Roberts, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 6, 2017
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1
Haruko Tashiro, Tim Sauer, Thomas Shum, et al.
Blood
|
July 29, 2021
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity
Tim Sauer, Kathan Parikh, Sandhya Sharma, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 28, 2017
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells
Michael Schmueck-Henneresse, Bilal Omer, Thomas Shum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2017
Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
Miyuki Tanaka, Haruko Tashiro, Bilal Omer, et al.
Bone Marrow Transplantation
|
July 18, 2021
Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children's Hospital experience
Tami D John, Brian Friend, Khaled Yassine, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
December 8, 2009
Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trial
Simone Krebs, Talib N Omer, Bilal Omer
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 17, 2010
Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial
Simone Krebs, Bilal Omer, Talib Noor Omer, et al.
Cancer Immunology Research
|
January 18, 2019
NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors
Robin Parihar, Charlotte Rivas, Mai Huynh, et al.
Cancer Immunology Research
|
September 1, 2025
Tunneling CARs: Increasing CAR T-cell tumor infiltration through the overexpression of MMP-7 and Osteopontin-b
Stacey Van Pelt, Mark White, Candise Tat, et al.
British Journal of Haematology
|
July 11, 2012
Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults
Bilal Omer, Nina S Kadan-Lottick, Kenneth B Roberts, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 6, 2017
Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1
Haruko Tashiro, Tim Sauer, Thomas Shum, et al.
Blood
|
July 29, 2021
CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity
Tim Sauer, Kathan Parikh, Sandhya Sharma, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 28, 2017
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells
Michael Schmueck-Henneresse, Bilal Omer, Thomas Shum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2017
Vaccination Targeting Native Receptors to Enhance the Function and Proliferation of Chimeric Antigen Receptor (CAR)-Modified T Cells
Miyuki Tanaka, Haruko Tashiro, Bilal Omer, et al.
Bone Marrow Transplantation
|
July 18, 2021
Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children's Hospital experience
Tami D John, Brian Friend, Khaled Yassine, et al.
Page
of 4